Twist Bioscience Corp vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.67. The key difference: Twist Bioscience Corp is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| TWST | YMAG | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $102.88 | $15.98 |
52-Week Low | $24.16 | $11.00 |
Enterprise Value | $5.37B | — |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →